Pro Share Advisors LLC Dynavax Technologies Corp Transaction History

Pro Share Advisors LLC

  • $48.7 Billion
  • Q2 2025

A detailed history of Pro Share Advisors LLC transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Pro Share Advisors LLC holds 28,085 shares of DVAX stock, worth $278,884. This represents 0.0% of its overall portfolio holdings.

Number of Shares
28,085
Previous 36,437 22.92%
Holding current value
$278,884
Previous $472,000 41.1%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 07, 2025
SELL
$9.4 - $12.87 $78,508 - $107,490
-8,352 Reduced 22.92%
28,085 $278,000
Q1 2025

May 08, 2025
SELL
$12.39 - $14.4 $115,251 - $133,948
-9,302 Reduced 20.34%
36,437 $472,000
Q4 2024

Feb 13, 2025
BUY
$10.28 - $13.66 $110,047 - $146,230
10,705 Added 30.56%
45,739 $584,000
Q3 2024

Nov 13, 2024
BUY
$10.05 - $11.61 $70,138 - $81,026
6,979 Added 24.88%
35,034 $390,000
Q2 2024

Aug 13, 2024
SELL
$10.73 - $12.58 $77,406 - $90,752
-7,214 Reduced 20.45%
28,055 $315,000
Q1 2024

May 08, 2024
BUY
$11.7 - $14.98 $31,484 - $40,311
2,691 Added 8.26%
35,269 $437,000
Q4 2023

Feb 14, 2024
BUY
$13.09 - $14.98 $168,507 - $192,837
12,873 Added 65.33%
32,578 $455,000
Q3 2023

Nov 13, 2023
SELL
$12.64 - $14.99 $3,450 - $4,092
-273 Reduced 1.37%
19,705 $291,000
Q2 2023

Aug 10, 2023
BUY
$9.85 - $13.17 $26,319 - $35,190
2,672 Added 15.44%
19,978 $258,000
Q1 2023

May 11, 2023
SELL
$9.44 - $11.88 $14,480 - $18,223
-1,534 Reduced 8.14%
17,306 $169,000
Q4 2022

Feb 02, 2023
BUY
$10.27 - $13.29 $26,609 - $34,434
2,591 Added 15.95%
18,840 $200,000
Q3 2022

Nov 04, 2022
SELL
$9.93 - $17.44 $4,120 - $7,237
-415 Reduced 2.49%
16,249 $170,000
Q2 2022

Aug 01, 2022
SELL
$7.45 - $12.83 $26,454 - $45,559
-3,551 Reduced 17.57%
16,664 $210,000
Q1 2022

May 10, 2022
SELL
$9.75 - $14.44 $32,574 - $48,244
-3,341 Reduced 14.18%
20,215 $219,000
Q4 2021

Feb 08, 2022
BUY
$13.17 - $20.94 $128,367 - $204,102
9,747 Added 70.58%
23,556 $332,000
Q3 2021

Nov 12, 2021
SELL
$9.16 - $19.83 $129,705 - $280,792
-14,160 Reduced 50.63%
13,809 $265,000
Q2 2021

Aug 13, 2021
SELL
$7.25 - $10.99 $2,878 - $4,363
-397 Reduced 1.4%
27,969 $275,000
Q1 2021

May 14, 2021
BUY
$4.57 - $11.18 $22,063 - $53,977
4,828 Added 20.51%
28,366 $279,000
Q4 2020

Feb 09, 2021
BUY
$3.73 - $5.6 $39,224 - $58,889
10,516 Added 80.76%
23,538 $105,000
Q3 2020

Nov 13, 2020
BUY
$4.32 - $11.7 $3,745 - $10,143
867 Added 7.13%
13,022 $56,000
Q2 2020

Aug 03, 2020
BUY
$2.94 - $9.1 $35,735 - $110,610
12,155 New
12,155 $108,000
Q1 2020

May 15, 2020
SELL
$2.27 - $6.2 $25,646 - $70,047
-11,298 Closed
0 $0
Q4 2019

Feb 12, 2020
BUY
$3.46 - $6.93 $39,091 - $78,295
11,298 New
11,298 $65,000

Others Institutions Holding DVAX

# of Institutions
294
Shares Held
121M
Call Options Held
294K
Put Options Held
77.6K
View Full List

About DYNAVAX TECHNOLOGIES CORP

DVAX Quotes by TradingView
  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.26B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email